Alpha-Melanocyte-Stimulating Hormone Maintains Retinal Homeostasis after Ischemia/Reperfusion
Biomolecules · 2024
DOI: 10.3390/biom14050525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Tat Fong Ng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Boston University Chobanian & Avedesian School of Medicine, Boston, MA 02118, USA. Hauptthemen laut MEDLINE: alpha-MSH, Apoptosis, Homeostasis, Reperfusion Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Boston University Chobanian & Avedisian School of Medicine Wing Tat Lee Award, Massachusetts Lions Eye Research Fund.
Abstract (Originalsprache)
Augmenting the natural melanocortin pathway in mouse eyes with uveitis or diabetes protects the retinas from degeneration. The retinal cells are protected from oxidative and apoptotic signals of death. Therefore, we investigated the effects of a therapeutic application of the melanocortin alpha-melanocyte-stimulating hormone (α-MSH) on an ischemia and reperfusion (I/R) model of retinal degenerative disease. Eyes were subjected to an I/R procedure and were treated with α-MSH. Retinal sections were histopathologically scored. Also, the retinal sections were immunostained for viable ganglion cells, activated Muller cells, microglial cells, and apoptosis. The I/R caused retinal deformation and ganglion cell loss that was significantly reduced in I/R eyes treated with α-MSH. While α-MSH treatment marginally reduced the number of GFAP-positive Muller cells, it significantly suppressed the density of Iba1-positive microglial cells in the I/R retinas. Within one hour after I/R, there was apoptosis in the ganglion cell layer, and by 48 h, there was apoptosis in all layers of the neuroretina. The α-MSH treatment significantly reduced and delayed the onset of apoptosis in the retinas of I/R eyes. The results demonstrate that therapeutically augmenting the melanocortin pathways preserves retinal structure and cell survival in eyes with progressive neuroretinal degenerative disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Boston University Chobanian & Avedesian School of Medicine, Boston, MA 02118, USA.
- Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
ORCID-Profile: John L Zhao, Samantha L Fineman, Amy C Lo, Andrew W Taylor
Förderung
- NEI NIH HHS
- Boston University Chobanian & Avedisian School of Medicine Wing Tat Lee Award
- Massachusetts Lions Eye Research Fund
- Massachusetts Lions Eye Research Foundation
- Boston University Chobanian & Avedisian School of Medicine Wing Tat Lee Award
Zitieren
APA
Ng, T. F., Cho, J. Y., Zhao, J. L., Gardiner, J. R., Wang, E. S., Leung, E., Xu, Z., Fineman, S. L., Lituchy, M., Lo, A. C., & Taylor, A. W. (2024). Alpha-Melanocyte-Stimulating Hormone Maintains Retinal Homeostasis after Ischemia/Reperfusion. Biomolecules. https://doi.org/10.3390/biom14050525
Vancouver
Ng TF, Cho JY, Zhao JL, Gardiner JR, Wang ES, Leung E, et al. Alpha-Melanocyte-Stimulating Hormone Maintains Retinal Homeostasis after Ischemia/Reperfusion. Biomolecules. 2024. doi:10.3390/biom14050525
BibTeX
@article{Ng2024,
author = {Ng, Tat Fong and Cho, Jenna Y and Zhao, John L and Gardiner, John R and Wang, Eric S and Leung, Elman and Xu, Ziqian and Fineman, Samantha L and Lituchy, Melinda and Lo, Amy C and Taylor, Andrew W},
title = {Alpha-Melanocyte-Stimulating Hormone Maintains Retinal Homeostasis after Ischemia/Reperfusion},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14050525}
}
EUVIMED